Rivera-Morales Mark D, Pell Robert, Rubero Jose, Ganti Latha
Emergency Medicine, University of Central Florida College of Medicine/ HCA Healthcare Graduate Medical Education Consortium, Orlando, USA.
Emergency Medicine, Emergency Medicine Residency Program of Greater Orlando, Orlando, USA.
Cureus. 2020 Oct 29;12(10):e11247. doi: 10.7759/cureus.11247.
The COVID-19 viral infection, caused by the novel coronavirus severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is a currently ongoing global pandemic that, as of mid-October, 2020, has resulted in more than 38.7 million confirmed cases globally and has caused more than 1.1 million fatalities. COVID-19 infection is associated with severe life threatening respiratory and cardiac complications such as acute respiratory distress syndrome (ARDS), pneumonia, shock, cardiac arrhythmias, myocardial infarction and heart failure, particularly in the acute infectious stage. Acute myopericarditis is another reported cardiac complication of COVID-19. Case reports have been limited in reporting the effects of COVID-19 in the post-symptomatic period. In this article, we present a case of acute myopericarditis resulting 6 to 8 weeks after testing positive for COVID-19. Here we will breakdown the initial emergency department (ED) presentation, with particular attention to the electrocardiogram (ECG) findings of acute myopericarditis. This case, to the our best knowledge and after an extensive literature review, depicts the first case of myopericarditis in the post COVID-19 infection recovery phase.
新型冠状病毒严重急性呼吸综合征冠状病毒2（SARS-CoV-2）引起的2019冠状病毒病（COVID-19）病毒感染，是一场目前仍在全球范围内肆虐的大流行疾病。截至2020年10月中旬，全球确诊病例已超过3870万例，死亡人数超过110万。COVID-19感染与严重的危及生命的呼吸和心脏并发症相关，如急性呼吸窘迫综合征（ARDS）、肺炎、休克、心律失常、心肌梗死和心力衰竭，尤其是在急性感染阶段。急性心肌心包炎是另一种已报道的COVID-19心脏并发症。关于COVID-19在症状消失期影响的病例报告有限。在本文中，我们介绍一例在COVID-19检测呈阳性6至8周后发生急性心肌心包炎的病例。在此，我们将详细分析最初在急诊科的表现，尤其关注急性心肌心包炎的心电图（ECG）表现。据我们所知，经过广泛的文献检索，该病例描述了COVID-19感染恢复阶段首例心肌心包炎病例。
